Brazil court strips Gilead of hepatitis C drug patent
A Brazilian court has stripped the patent protection of a Gilead Sciences Inc big-selling hepatitis C treatment in Brazil at the behest of a presidential candidate who pushed for the move, paving the way for cheaper generics.
from Reuters: Health News https://reut.rs/2Q0KJ0g
http://bit.ly/2zwRqiM